Search research articles
Contact Us
Filters
Showing results (411-420 of 432) with videos related to
Page
of 44
Sort By:
Cephalalgia : an International Journal of Headache
|
January 6, 2023
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Edoardo Caronna, Thomas C van den Hoek, Hayrunnisa Bolay, et al.
Cephalalgia : an International Journal of Headache
|
September 17, 2019
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial
Hans-Christoph Diener, Peter J Goadsby, Messoud Ashina, et al.
Lancet (London, England)
|
July 29, 2023
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Patricia Pozo-Rosich, Jessica Ailani, Messoud Ashina, et al.
The Journal of Headache and Pain
|
June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache
|
November 21, 2023
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 1, 2025
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
Cephalalgia : an International Journal of Headache
|
July 30, 2020
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
Hans-Christoph Diener, Cristina Tassorelli, David W Dodick, et al.
Cephalalgia : an International Journal of Headache
|
February 21, 2025
Setting higher standards for migraine prevention: A position statement of the International Headache Society
Simona Sacco, Messoud Ashina, Hans-Christoph Diener, et al.
The Journal of Headache and Pain
|
April 9, 2021
Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020
Henrik W Schytz, Faisal M Amin, Rigmor H Jensen, et al.
Annals of Neurology
|
March 27, 2021
Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients
Hashmat Ghanizada, Mohammad Al-Mahdi Al-Karagholi, Christopher S Walker, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 432) with videos related to
Sort By:
Page
of 44
Cephalalgia : an International Journal of Headache
|
January 6, 2023
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Edoardo Caronna, Thomas C van den Hoek, Hayrunnisa Bolay, et al.
Cephalalgia : an International Journal of Headache
|
September 17, 2019
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial
Hans-Christoph Diener, Peter J Goadsby, Messoud Ashina, et al.
Lancet (London, England)
|
July 29, 2023
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Patricia Pozo-Rosich, Jessica Ailani, Messoud Ashina, et al.
The Journal of Headache and Pain
|
June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache
|
November 21, 2023
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 1, 2025
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
Cephalalgia : an International Journal of Headache
|
July 30, 2020
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
Hans-Christoph Diener, Cristina Tassorelli, David W Dodick, et al.
Cephalalgia : an International Journal of Headache
|
February 21, 2025
Setting higher standards for migraine prevention: A position statement of the International Headache Society
Simona Sacco, Messoud Ashina, Hans-Christoph Diener, et al.
The Journal of Headache and Pain
|
April 9, 2021
Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020
Henrik W Schytz, Faisal M Amin, Rigmor H Jensen, et al.
Annals of Neurology
|
March 27, 2021
Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients
Hashmat Ghanizada, Mohammad Al-Mahdi Al-Karagholi, Christopher S Walker, et al.
Page
of 44